AGP Executive Report
Last update: 9 hours agoTB supply delays in the Philippines: Acting Health Secretary Edwin Mercado says anti-TB medicines and testing cartridges could be delivered as early as October/November after bids run Sept. 3–10, following past procurement criticism. Leptospirosis readiness: The DOH reports about 3.1 million doxycycline pills in stock to cover flood-borne illness demand, with next-year procurement planned. Medicaid rule changes in North Carolina: NCDHHS released a toolkit explaining new NC Medicaid rules starting Oct. 1, 2026. Trans care oversight in Connecticut: Lawmakers threaten subpoenas over Connecticut Children’s Medical Center’s agreement to end gender-affirming services for trans youth. Fall prevention push: A geriatrician urges annual fall-risk assessments for adults 65+ and medication/balance review. Medicare payment proposal: CMS’s 2027 physician fee schedule draft includes major proposed changes, including potential 50% cuts for certain same-visit procedure/E&M overlaps. Pharma enforcement in India: Gujarat FDCA cancelled licenses of 50 pharma firms and ordered closures over illegal medicines. AI drug discovery: Insilico Medicine released new frontier specialist AI models for chemistry and biology. Atrial fibrillation trial in Texas: St. David’s Medical Center’s Texas Cardiac Arrhythmia Institute is first in the U.S. to test a pulsed field ablation mapping system.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
